Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin-Reference-Cited by-同舟云学术

Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin

Published:2018-10-03 Issue:2 Volume:21 Page:408-411
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Yu Miao¹,Shankar R. Ravi²^ORCID,Zhang Ruya³,Zhang Ye³,Lin Jianxin²,O'Neill Edward A.²,Chen Guojuan³,Liu Shu⁴,Tu Yingmei⁴,Engel Samuel S.²^ORCID

Affiliation:

1. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital; Chinese Academy of Medical Sciences; Beijing China

2. Merck & Co., Inc; Kenilworth New Jersey

3. MSD China Holding Company; Shanghai China

4. Clinical Research; MSD China R&D Center; Beijing China

Funder

Merck Sharp & Dohme Corp

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13517/fullpdf

Reference18 articles.

1. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

2. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes;Janka;Diabetes Care,2005

3. Standards of care for type 2 diabetes in China;Weng;Diabetes Metab Res Rev,2016

4. Sitagliptin: a review of its use in patients with type 2 diabetes mellitus;Plosker;Drugs,2014

5. Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes;Vilsboll;Diabetes Obes Metab,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network meta-analysis of glucose-lowering drug treatment regimens with the potential risk of hypoglycemia in patients with type 2 diabetes mellitus in terms of glycemic control and severe hypoglycemia;Journal of Investigative Medicine;2023-01-25

2. Efficacy and Cardiovascular Safety of DPP-4 Inhibitors;Current Drug Safety;2021-06-08

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-08